Resurgence of interest in ammonia metabolism in liver disease has resulted in extensive use of the blood ammonia determination as a clinical and investigative tool. Almost all methods for the determination of ammonia in blood are based on the liberation of ammonia by alkalinization, diffusion of the ammonia into an acid medium, followed by titrimetric or colorimetric quantitation. Although widely used, these measurements have been accepted with reservations for several reasons. First, a wide variation in the normal range of blood ammonia concentration has been reported from various laboratories."5 These may be attributed to technical differences in degree of alkalinization, "'8 duration of diffusion,8'e'9 interval between the shedding of blood and its analysis," "' temperature1' l" and other factors. Secondly, there has been controversy over whether free ammonia actually exists in the circulating blood of normal individuals. Conway observed a sharp rise in the blood ammonia concentration immediately after shedding and concluded that the circulating blood of normal individuals does not contain free ammonia.' Some investigators have confirmed this observatione9'1 but others, using the same or different methods, have been unable to do so.' 7'-'l Although it appears that free ammonia does exist in blood in low concentrations,19'f one must assume that the blood ammonia levels, as measured by some, if not all, of these different techniques, are artifactually high or low.
The recent observation that different commercial brands and concentrations of heparin contain variable amounts of ammonia which may artifactually affect the blood ammonia level,' has led to investigations of the effect of other anticoagulants. Use of anticoagulants such as heparin, potassium oxalate and sodium fluoride, which are themselves ammonia-free, may affect the blood ammonia determination to different degrees.-' These observations suggest possible explanations for some of the variations in blood ammonia levels reported in the literature. Furthermore, investigation of the effect of various anticoagulants on the blood ammonia concentration may provide a clue to the source and significance of the ammonia found in blood.
The present study was undertaken to evaluate the effect of various anticoagulants on the blood ammonia determination, and to investigate the nature of these phenomena.
METHODS AND MATERIALS
All blood ammonia determinations were performed in duplicate or triplicate using the Seligson-Hirahara technique.4 Sodium heparin solution (10 mg. per ml., Organon, Inc.), which contained negligible amounts of ammonia, was used as the reference anticoagulant with which other anticoagulants were compared.' The other anticoagulants, which included sodium oxalate, potassium oxalate, sodium citrate, sodium ethylenediaminetetraacetate (EDTA) and sodium fluoride, were rendered ammoniafree by alkalinization and recrystallization after readjustment of pH to 7.4. Blood was drawn without stasis into dry sterile syringes, immediately transferred to test tubes containing measured amounts of the appropriate anticoagulants and mixed by gentle inversion. After 10 minutes at room temperature the test tubes were again mixed and the ammonia concentration measured.
The ammonia concentration of heparinized blood was compared in turn with blood anticoagulated with each of the other anticoagulants, and with non-anticoagulated blood. The order of analysis was randomized within each series of comparisons which consisted of at least 25 different blood specimens. In each series the blood was obtained predominantly from cirrhotic patients, but also from patients with a variety of other disorders, and from normal subjects.
The effect of temperature was studied by simultaneously incubating aliquots of blood which had been anticoagulated with heparin, potassium oxalate, and sodium fluoride in constant temperature water baths at 20 C., room temperature (mean 220 C.), and 38°C. The order of analysis was rotated' in regard to the anticoagulant and the temperature of incubation.
Studies to investigate the effect of the interval between the withdrawal of blood and its analysis in respect to the effect of each anticoagulant on the blood ammonia concentration were carried out in the following manner. Venous blood was rapidly drawn into calibrated two ml. syringes containing measured amounts of anticoagulant solution, and immediately ejected into the alkali-containing diffusion bottles through a three-way stopcock (Fig. 1) . A fresh syringe was used for each of four samples. The average time interval from the appearance of blood in the syringe to its delivery into the diffusion bottle was eight seconds and ranged from 5 to 12 seconds. Although the volume of blood transferred was approximately two ml. in all instances, the exact volume was determined by weight, and the blood ammonia concentration was corrected for variations in volume. Immediately after the fourth sample, blood was withdrawn and anticoagulated in the usual manner and the blood ammonia concentration determined after C;4.:.
* :
FIG. 1. Method employed to introduce blood into reaction vessel within a few seconds of withdrawal. As soon as the syringe had been filled to the 2 ml. mark the stopcock was turned and the blood ejected into the alkali-containing reaction bottle. 10 and 20 minute incubation periods at room temperature. Each anticoagulant was studied in this manner on at least ten occasions. A heparinized blood sample served as a reference value when other anticoagulants were being studied. The effect of the various anticoagulants on the pH of blood was determined immediately after withdrawal and at intervals up to 20 minutes with the Metrohm pH meter.*
RESULTS
The concentrations of the various anticoagulants and their effects on the blood ammonia determination are summarized in Table 1 . Sodium Ethylenediaminetetraacetate (EDTA). The ammonia concentration of blood specimens which were anticoagulated with EDTA or heparin were virtually identical. In a separate series of analyses the ammonia levels of blood anticoagulated with a commercial preparation of EDTA (Sequestrene Vacutainers®) were slightly, but significantly, higher than with heparinized blood (Table 2 ). This mean increment of 5.6 ,ug. per 100 ml. was due to contamination of the EDTA with small amounts of ammonia which added approximately 6 ,ug. per 100 ml. to each blood sample. Although this small increment was of no practical importance, it demonstrated the accurate recovery by this technique of small amounts of ammonia added to blood. There was no difference in the blood ammonia level when either liquid or powdered EDTA was used, or when the pH of the EDTA was neutral or alkaline (pH 10) ( Table 2 ). The ammonia concentration of blood which was anticoagulated with EDTA remained constant from the time of withdrawal for at least twenty minutes after shedding (FIG. 2) (Table 3 ). Prior heparinization of the blood did not prevent the increment (Table 3) . Immediately after shedding, the ammonia levels of oxalated blood were identical with those of heparinized blood. The ammonia concentration of oxalated blood, however, rose as a function of the interval between the time of shedding and its analysis (Fig. 2) . These increments The oxalate-induced rise in blood ammonia concentration was minimized in the cold, and accelerated by increasing the temperature. The ammonia concentration of heparinized blood, however, was not temperature-dependent (Fig. 3) blood anticoagulated with heparin. There was no significant difference in blood ammonia levels between sodium fluoride employed as a solution or as a powder (Table 4 ). Increasing the concentration of sodium fluoride from 2.5 to 10 mg. per ml. blood did not alter the magnitude of the increment in blood ammonia concentration (Table 4 ). Prior heparinization of the blood did not prevent the rise in blood ammonia levels induced by sodium fluoride (Table 4) .
Immediately after shedding, the ammonia concentration of fluoridated blood was almost identical with heparinized blood. The ammonia concentration of blood anticoagulated with sodium fluoride rose progressively thereafter as a function of the time interval between its withdrawal and H H its analysis (Fig. 2) . This rise could be prevented by incubation at 20 C. and accelerated at 380 C. (Fig. 3) . Fluoride-induced increments in ammonia concentration at various temperatures were much greater than those observed with potassium oxalate. No anticoagulation. A small but statistically significant increase in the ammonia concentration of unanticoagulated blood was observed as compared to heparinized blood (Table 1) .
No significant change in the pH of blood occurred during the twenty minutes after shedding with any of the anticoagulants employed. The only previous investigations on the effects of different anticoagulants on the blood ammonia determination were reported by De Groote and Vandenbroucke.' These authors using the Seligson-Seligson ammonia method' found no significant difference in the ammonia concentration of blood anticoagulated with heparin or EDTA. They observed small increments with sodium citrate and potassium oxalate, which were exaggerated by prolonged incubation.
The present studies confirm and extend these observations. Heparin and EDTA appear to have a similar effect. Identical blood ammonia levels are found with these anticoagulants, and they remain constant for at least twenty minutes after withdrawal. Furthermore, incubation over a wide temperature range causes no appreciable change in the blood ammonia concentration.
Although heparinized and oxalated blood have the same ammonia concentration at the time of shedding, potassium oxalate induces a moderate rise in the blood ammonia concentration which increases as the interval between its withdrawal and analysis lengthens. This can be inhibited almost completely by lowering the temperature to 2°C., and accelerated by increasing the temperature to 380 C. Despite the similar blood ammonia levels of heparinized and fluoridated blood at the time of withdrawal, sodium fluoride induces a large increase in the blood ammonia concentration. This increment which rises as a function of the time after shedding, can be minimized in the cold or enormously enhanced by increasing the temperature of incubation to 380 C. The slightly higher levels of ammonia observed in blood anticoagulated with oxalate or fluoride at 20 C. probably represented increments which took place during temperature equilibration.
The ammonia concentration of non-anticoagulated blood is slightly, but significantly, higher than heparinized blood. Blood anticoagulated with sodium citrate also gave ammonia values slightly higher than heparinized blood.
The magnitude of the anticoagulant-induced increments were independent of the basal blood ammonia level, and of the presence or absence of cirrhosis.
The explanation for these phenomena is not apparent. These observations, however, do permit the formulation of several working hypotheses. The first, which may be considered a "unified" hypothesis, suggests that there occurs a gradual increase in ammonia concentration of blood after withdrawal from the body. This small increment which occurs even in nonanticoagulated blood may be considered a natural phenomenon. It may be prevented, however, by anticoagulation with heparin or EDTA, but may be unaffected by sodium citrate. Potassium oxalate and sodium fluoride potentiate the ammonia-liberating process to different degrees.
The second, a non-unified assumption, presupposes that the "natural"
rise in ammonia levels of non-anticoagulated blood is a function of the coagulation process, which may be prevented by any anticoagulants. This implies that sodium citrate, potassium oxalate and sodium fluoride exert their effects by different mechanisms, or conceivably, by influencing the same mechanism to different degrees. By what mechanisms might these anticoagulant-induced effects be mediated? It is unlikely that they are related to the anticoagulant activity, per se, of these substances. Although the anticoagulant mechanisms of heparin and EDTA are entirely different their effects on the blood ammonia determination are similar. Conversely, although the anticoagulant activities of EDTA, sodium citrate, potassium oxalate, and sodium fluoride are dependent on the binding of calcium, their effects on the blood ammonia determination are entirely different.
Conway's suggestion that adenylic acid or adenosine gives rise to ammonia in vitro is an attractive one.' These nitrogenous substances are among the few which liberate ammonia after incubation with blood by both the Conway and Seligson methods2'' due to the presence of the appropriate deaminases in blood. Furthermore, heparin, in the concentration employed, is a potent inhibitor of adenylic acid deaminase.' Although neither potassium oxalate nor sodium fluoride are known to potentiate the activity of these enzymes, both are potent inhibitors of glycolysis" D Either of these anticoagulants, by interfering with the energy metabolism of the erythrocytes and accelerating the breakdown of ATP' may provide sufficient substrate for the liberation of ammonia by erythrocyte adenylic acid and adenosine deaminases. Gardos, who noted similar changes in the ammonia concentration of blood in unpublished studies, postulated a similar mechanism.' It is also conceivable that these anticoagulants which profoundly alter the permeability of the red cell membrane may permit the release of ammonia-liberating substances, such as adenylic acid deaminase, in a manner analogous to the efflux of potassium induced by sodium fluoride-" An incidental finding of this investigation was the demonstration of significant amounts of ammonia in blood a few seconds after withdrawal, regardless of the anticoagulant employed. When heparin or EDTA was used this level remained constant for periods in excess of 20 minutes. With oxalated or fluoridated blood the ammonia concentration gradually increased as a function of time. These observations, which were made on both normal subjects and patients with hepatic disorders, contradict those of Conway and Cooke" ' who found no ammonia in oxalated blood immediately after withdrawal. They noted a sharp rise in the blood ammonia concentration for about three minutes after which it leveled off. Although some authors have confirmed Conway's findings0 ' others, using the same method, have been unable to do so.""' Conway's observations have not been confirmed when other analytic techniques have been employed."" '- '5 '-1 The explanation for these discordant results is not clear, although it appears that basic differences in the analytic methods are responsible.
Conway's findings have led to the conclusion that free ammonia does not exist normally in blood. The observations of significant amounts of ammonia in blood immediately after withdrawal imply opposite conclusions. Recent studies by Jacquez and Robin, and their coworkers, have demonstrated the presence of ammonia in expired air in concentrations similar to those measured by the Seligson-Hirahara and related methods.'9' f' It is hoped that further investigations, which are currently in progress, may provide better understanding of the source and significance of ammonia in blood.
SUMMARY
The ammonia concentration of blood anticoagulated in vitro with heparin or EDTA was identical. Progressively higher blood ammonia values were found when sodium citrate, potassium oxalate and sodium fluoride were used as anticoagulants. The ammonia concentration of blood measured within a few seconds of withdrawal was the same with each of these anticoagulants. A progressive increase in the ammonia level of blood anticoagulated with potassium oxalate or sodium fluoride occurred as a function of the time interval after shedding. No such increase took place with heparinized or versenated blood. These anticoagulant-induced increments were prevented by incubation at 20 C. and were accelerated at 380 C.
These phenomena may be directly related to the inhibition of glycolysis in the erythrocytes by the fluoride or oxalate, or, indirectly, to alterations in red cell permeability induced by these substances.
The demonstration of ammonia in blood immediately after withdrawal supports the concept that free ammonia is present in circulating blood.
